Publicacions
-
Muraro A, de Silva D, Podesta M, Anagnostou A, Cardona V, Halken S, Smith P, Tanno LK, Turner P, Worm M, Alvaro-Lozano M, Arasi S, Asarnoj A, Barni S, Beyer K, Bilaver LA, Bird A, Bonaguro R, Brough HA, Chinthrajah RS, Cook EE, Demoulin C, Deschildre A, Dribin TE, Ebisawa M, Fernandez-Rivas M, Fiocchi A, Fleischer DM, Garrow E, Gerdts J, Giovannini M, Järvinen KM, Kelly M, Knol EF, Lack G, Lazzarotto F, Le TM, Leonard S, Lieberman J, Makris M, Mandelbaum L, Marchisotto MJ, Marino GA, Mori F, Nilsson C, Nowak-Wegrzyn A, Odemyr M, Oude Elberink HNG, Palosuo K, Patel N, Pier J, Poblete S, Rachid R, Rodríguez Del Río P, Said M, Sampson HA, Sánchez Sanz A, Schnadt S, Schultz F, Toniolo A, Upton JEM, Venter C, Vickery BP, Vlieg-Boerstra B, Wang J, Roberts G and Zuberbier T.
10 practical priorities to prevent and manage serious allergic reactions: GA(2)LEN ANACare and EFA Anaphylaxis Manifesto.
Clinical and Translational Allergy . 14(12): .
-
Zuberbier T, Muraro A, Nurmatov U, Arasi S, Stevanovic K, Anagnostou A, Bonaguro R, Chinthrajah S, Lack G, Fiocchi A, Le TM, Turner P, Alvaro-Lozano M, Angier E, Barni S, Bégin P, Ballmer-Weber B, Cardona V, Bindslev-Jensen C, Cianferoni A, de Jong N, de Silva D, Deschildre A, Galvin AD, Ebisawa M, Fleischer DM, Gerdts J, Giovannini M, Gradman J, Halken S, Arshad SH, Khaleva E, Lau S, Loh R, Mäkelä MJ, Marchisotto MJ, Morandini L, Mortz CG, Nilsson C, Nowak-Wegrzyn A, Podestà M, Poulsen LK, Roberts G, Rodríguez Del Río P, Sampson HA, Sánchez A, Schnadt S, Smith PK, Szajewska H, Mitrevska NT, Toniolo A, Venter C, Warner A, Wong GWK, Wood R and Worm M.
GA2LEN ANACARE consensus statement: Potential of omalizumab in food allergy management
Clinical and Translational Allergy . 14(11): .
-
Rodríguez Del Río P, Alvaro-Lozano M, Arasi S, Bazire R, Escudero C, Patel N, Mónica Paola Sandoval Ruballos, Vazquez-Ortiz M, Nowak-Wegrzyn A, Blümchen K, Dunn Galvin A, Deschildre A, Greenhawt M, Schnadt S, Riggioni C, Remington BC, Turner P and Fernandez Rivas M.
Evaluation of clinical outcomes of efficacy in food allergen immunotherapy trials, COFAITH EAACI task force
ALLERGY . 79(4): 793-822. Nº de cites: 6
-
Santos AF, Riggioni C, Agache I, Akdis CA, Akdis M, Alvarez-Perea A, Alvaro-Lozano M, Ballmer-Weber B, Barni S, Beyer K, Bindslev-Jensen C, Brough HA, Buyuktiryaki B, Chu D, Del Giacco S, Dunn-Galvin A, Eberlein B, Ebisawa M, Eigenmann P, Eiwegger T, Feeney M, Fernandez-Rivas M, Fisher HR, Fleischer DM, Giovannini M, Gray C, Hoffmann-Sommergruber K, Halken S, Hourihane JO, Jones CJ, Jutel M, Knol E, Konstantinou GN, Lack G, Lau S, Marques Mejias A, Marchisotto MJ, Meyer R, Mortz CG, Moya B, Muraro A, Nilsson C, Lopes de Oliveira LC, O'Mahony L, Papadopoulos NG, Perrett K, Peters RL, Podesta M, Poulsen LK, Roberts G, Sampson HA, Schwarze J, Smith P, Tham EH, Untersmayr E, Van Ree R, Venter C, Vickery BP, Vlieg-Boerstra B, Werfel T, Worm M, Du Toit G and Skypala I.
EAACI guidelines on the diagnosis of IgE-mediated food allergy
ALLERGY . 78(12): 3057-3076. Nº de cites: 65
-
Staubach P, Alvaro-Lozano M, Sekerel BE, Maurer M, Ben-Shoshan M, Porter M, Hua E, Ji Y, Burciu A, Savelieva M, Severin T, Drollmann A and Bienczak A.
Ligelizumab in adolescents with chronic spontaneous urticaria: Results of a dedicated phase 2b randomized clinical trial supported with pharmacometric analysis
PEDIATRIC ALLERGY AND IMMUNOLOGY . 34(7): . Nº de cites: 8
-
Sahiner, UM, Giovannini, M, Escribese, MM, Paoletti, G, Heffler, E, Alvaro-Lozano M, Barber, D, Canonica, GW and Pfaar, O.
Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation
Journal of Personalized Medicine . 13(5): . Nº de cites: 14
-
Arasi S, Nurmatov U, Dunn-Galvin A, Roberts G, Turner PJ, Shinder SB, Gupta R, Eigenmann P, Nowak-Wegrzyn A, Ansotegui IJ, Rivas MF, Petrou S, Tanno LK, Vazquez-Ortiz M, Vickery B, Wong G, Alvaro-Lozano M, Asaria M, Begin P, Bozzola M, Boyle R, Brough H, Cardona V, Chinthrajah RS, Cianferoni A, Deschildre A, Fleischer D, Gazzani F, Gerdts J, Giannetti M, Greenhawt M, Guzmán MA, Hossny E, Kauppi P, Jones C, Lucidi F, Monge Ortega OP, Munblit D, Muraro A, Pajno G, Podestà M, Rodriguez Del Rio P, Said M, Santos A, Shaker M, Szajewska H, Venter C, Warren C, Winders T, Ebisawa M and Fiocchi A.
WAO consensus on DEfinition of Food Allergy SEverity (DEFASE)
World Allergy Organization Journal . 16(3): 100753-100753. Nº de cites: 17
-
Mónica Paola Sandoval Ruballos, Domínguez-Sánchez O, de Landazuri, IO, Daniella Gereda Martinez, Michel Espinoza Cisneros, Sequeira, FQ, Rodriguez, SMR, Machinena A, Piquer-Gibert M, Folqué-Giménez MM, Lozano-Blasco J, Jiménez-Feijoo R, Pascal, M and Alvaro-Lozano M.
Pediatric chronic urticaria: Clinical and laboratory characteristics and factors linked to remission
PEDIATRIC ALLERGY AND IMMUNOLOGY . 34(3): . Nº de cites: 3
-
Munblit D, Greenhawt M, Brough HA, Pushkareva A, Karimova D, Demidova A, Warner JO, Kalayci O, Sediva A, Untersmayr E, Rodriguez Del Rio P, Vazquez-Ortiz M, Arasi S, Alvaro-Lozano M, Tsabouri S, Galli E, Beken B and Eigenmann PA.
Allergic diseases and immunodeficiencies in children, lessons learnt from COVID-19 pandemic by 2022: A statement from the EAACI-section on pediatrics
PEDIATRIC ALLERGY AND IMMUNOLOGY . 33(10): . Nº de cites: 6
-
de Silva D, Singh C, Arasi S, Muraro A, Zuberbier T, Ebisawa M, Alvaro-Lozano M and Roberts G.
Systematic review of monotherapy with biologicals for children and adults with IgE-mediated food allergy
Clinical and Translational Allergy . 12(9): . Nº de cites: 11